wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47143843-20104EF3-E52E-443B-B6C1-FF991C0DB019
Q47143843-20104EF3-E52E-443B-B6C1-FF991C0DB019
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47143843-20104EF3-E52E-443B-B6C1-FF991C0DB019
Antibody therapies for the prevention and treatment of viral infections.
P2860
Q47143843-20104EF3-E52E-443B-B6C1-FF991C0DB019
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47143843-20104EF3-E52E-443B-B6C1-FF991C0DB019
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a5c1624f61dbfb55b5f19ba85cb1b1c7661e874
P2860
A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.